A Single-Arm Phase II Study to Evaluate Efficacy and Safety of First-Line Treatment With DCVAC/LuCa, Standard of Care Chemotherapy and Shenqi Fuzheng Injection in Advanced (Stage IIIB/IV) Non-Small Cell Lung Cancer Patients

OBJECTIVES: To evaluate the efficacy and safety of first-line treatment with a dendritic cell vaccination for lung cancer (DCVAC/LuCa), standard of care chemotherapy and Shenqi Fuzheng injection in patients with advanced (stage IIIB/IV) non-small cell lung cancer. PATIENTS AND METHODS: Patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Qing, Lou, Yanni, Li, Liya, Yang, Guowang, Cui, Huijuan, Cheng, Zhiqiang, Li, Yuan, Liu, Meng, Deng, Chao, Wan, Donggui, Yan, Yongxia, Jia, Liqun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8943553/
https://www.ncbi.nlm.nih.gov/pubmed/35313775
http://dx.doi.org/10.1177/15347354221083968

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8943553/
https://www.ncbi.nlm.nih.gov/pubmed/35313775
http://dx.doi.org/10.1177/15347354221083968

Ejemplares similares